Roche Strikes $46.8 Billion Deal for Genentech
March 13, 2009 at 10:03 AM EDT
Big Pharma’s rapidly accelerating consolidation pattern snowballed yesterday (Thursday) as Roche Holding AG ( ADR : RHHBY ) struck a deal to buy the remaining shares it didn’t already own of Genentech Inc. ( DNA ) for $46.8 billion, or $95 each. The buyout ends a long battle by Basel, Switzerland-based Roche to acquire the U.S.…
